| Literature DB >> 26973881 |
Konrad Gabrusiewicz1, Benjamin Rodriguez2, Jun Wei1, Yuuri Hashimoto1, Luke M Healy3, Sourindra N Maiti4, Ginu Thomas5, Shouhao Zhou6, Qianghu Wang7, Ahmed Elakkad5, Brandon D Liebelt1, Nasser K Yaghi1, Ravesanker Ezhilarasan8, Neal Huang1, Jeffrey S Weinberg1, Sujit S Prabhu1, Ganesh Rao1, Raymond Sawaya1, Lauren A Langford9, Janet M Bruner9, Gregory N Fuller9, Amit Bar-Or3, Wei Li2, Rivka R Colen5, Michael A Curran10, Krishna P Bhat11, Jack P Antel3, Laurence J Cooper4, Erik P Sulman8, Amy B Heimberger1.
Abstract
Glioblastomas are highly infiltrated by diverse immune cells, including microglia, macrophages, and myeloid-derived suppressor cells (MDSCs). Understanding the mechanisms by which glioblastoma-associated myeloid cells (GAMs) undergo metamorphosis into tumor-supportive cells, characterizing the heterogeneity of immune cell phenotypes within glioblastoma subtypes, and discovering new targets can help the design of new efficient immunotherapies. In this study, we performed a comprehensive battery of immune phenotyping, whole-genome microarray analysis, and microRNA expression profiling of GAMs with matched blood monocytes, healthy donor monocytes, normal brain microglia, nonpolarized M0 macrophages, and polarized M1, M2a, M2c macrophages. Glioblastoma patients had an elevated number of monocytes relative to healthy donors. Among CD11b+ cells, microglia and MDSCs constituted a higher percentage of GAMs than did macrophages. GAM profiling using flow cytometry studies revealed a continuum between the M1- and M2-like phenotype. Contrary to current dogma, GAMs exhibited distinct immunological functions, with the former aligned close to nonpolarized M0 macrophages.Entities:
Year: 2016 PMID: 26973881 PMCID: PMC4784261 DOI: 10.1172/jci.insight.85841
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708